Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7–expressing Metastatic Castration-resistant Prostate Cancer-Reference-Cited by-同舟云学术

Androgen Receptor Modulation Optimized for Response—Splice Variant: A Phase 3, Randomized Trial of Galeterone Versus Enzalutamide in Androgen Receptor Splice Variant-7–expressing Metastatic Castration-resistant Prostate Cancer

Published:2019-12 Issue:6 Volume:76 Page:843-851
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Taplin Mary-Ellen,Antonarakis Emmanuel S.,Ferrante Karen J.,Horgan Kerry,Blumenstein Brent,Saad Fred,Luo Jun,de Bono Johann S.

Funder

Tokai Pharmaceuticals

Publisher

Elsevier BV

Subject

Urology

Reference26 articles.

1. Trial design and objectives for castration-resistant prostate cancer: updated recommendations from the Prostate Cancer Clinical Trials Working Group 3;Scher;J Clin Oncol,2016

2. Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects;Ferraldeschi;Oncogene,2015

3. Molecular processes leading to aberrant androgen receptor signaling and castration resistance in prostate cancer;Hu;Expert Rev Endocrinol Metab,2010

4. Prostate cancer: a new standard-of-care for advanced-stage disease;Hamid;Nat Rev Clin Oncol,2017

5. Abiraterone and increased survival in metastatic prostate cancer;de Bono;N Engl J Med,2011

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroidal 21-imidazolium salt derivatives: Synthesis and anticancer activity;Steroids;2024-10

2. Developmental Therapeutics in Metastatic Prostate Cancer: New Targets and New Strategies;Cancers;2024-09-06

3. Sterol-like drugs potentiate statin-triggered prostate cancer cell death by inhibiting SREBP2 nuclear translocation;Biomedicine & Pharmacotherapy;2024-08

4. Molecular landscape for risk prediction and personalized therapeutics of castration-resistant prostate cancer: at a glance;Frontiers in Endocrinology;2024-06-03

5. Circulating Biomarkers Predictive of Treatment Response in Patients with Hormone-sensitive or Castration-resistant Metastatic Prostate Cancer: A Systematic Review;European Urology Oncology;2024-05